Search Results - "Ashour, Nada A"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation by Antar, Samar A, Ashour, Nada A, Marawan, Mohamed E, Al-Karmalawy, Ahmed A

    “…Most chronic inflammatory illnesses include fibrosis as a pathogenic characteristic. Extracellular matrix (ECM) components build up in excess to cause fibrosis…”
    Get full text
    Journal Article
  2. 2

    Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments by Antar, Samar A., Ashour, Nada A., Sharaky, Marwa, Khattab, Muhammad, Ashour, Naira A., Zaid, Roaa T., Roh, Eun Joo, Elkamhawy, Ahmed, Al-Karmalawy, Ahmed A.

    Published in Biomedicine & pharmacotherapy (01-12-2023)
    “…Nowadays, diabetes mellitus has emerged as a significant global public health concern with a remarkable increase in its prevalence. This review article focuses…”
    Get full text
    Journal Article
  3. 3

    The journey of antimalarial drugs against SARS-CoV-2: Review article by Sarhan, Amany A., Ashour, Nada A., Al‐Karmalawy, Ahmed A.

    Published in Informatics in medicine unlocked (2021)
    “…The recent outbreak of coronavirus pandemic (COVID-19) introduced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the…”
    Get full text
    Journal Article
  4. 4

    Metformin role in Parkinson’s disease: a double-sword effect by Alrouji, Mohamed, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Ashour, Nada A., Jabir, Majid S., Negm, Walaa A., Batiha, Gaber El-Saber

    Published in Molecular and cellular biochemistry (01-04-2024)
    “…Parkinson’s disease (PD) is a common neurodegenerative disease developed due to the degeneration of dopaminergic neurons in the substantia nigra. There is no…”
    Get full text
    Journal Article
  5. 5

    Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management by Antar, Samar A., Ashour, Nada A., Hamouda, Amir O., Noreddin, Ayman M., Al‐Karmalawy, Ahmed A.

    Published in Inflammopharmacology (01-10-2024)
    “…Since the start of the pandemic, considerable advancements have been made in our understanding of the effects of SARS-CoV-2 infection and the associated…”
    Get full text
    Journal Article
  6. 6

    A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval by Ashour, Nada A, Abo Elmaaty, Ayman, Sarhan, Amany A, Elkaeed, Eslam B, Moussa, Ahmed M, Erfan, Ibrahim Ali, Al-Karmalawy, Ahmed A

    Published in Drug design, development and therapy (01-01-2022)
    “…The rising outbreak of SARS-CoV-2 continues to unfold all over the world. The development of novel effective antiviral drugs to fight against SARS-CoV-2 is a…”
    Get full text
    Journal Article
  7. 7

    Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach by Batiha, Gaber El-Saber, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Ashour, Nada A., Negm, Walaa A.

    Published in Inflammopharmacology (01-08-2023)
    “…In Covid-19, variations in fasting blood glucose are considered a distinct risk element for a bad prognosis and outcome in Covid-19 patients. Tirazepatide…”
    Get full text
    Journal Article